Skip to main content

Table 1 Comparison of general clinical data of EDM and MDM patients

From: Significant abnormal glycemic variability increased the risk for arrhythmias in elderly type 2 diabetic patients

Variables EDM MDM P
n 73 34  
Male [n,(%)] 56 (76.7) 22 (64.7) 0.536
Age(yrs) 81.08 ± 5.36 56.68 ± 5.24 < 0.001
BMI (kg/m) 25.68 ± 3.23 27.29 ± 3.50 0.021
SBP (mmHg) 142.03 ± 18.20 135.26 ± 23.12 0.139
DBP (mmHg) 68.25 ± 9.21 77.47 ± 14.41 0.001
Anti-diabetes drugs
 sulfonylurea [n, (%)] 13 (17.8) 6 (17.6) 0.507
 Insulin [n, (%)] 43 (58.9) 19 (55.9) 0.528
 Others [n, (%)] 17 (35.6) 9 (26.5) 0.223
 Metformin 10 7 0.3640
 α-glucosidase inhibitor 5 1 0.6621
 DPP 4 inhibitors 1 1 0.5366
 TZD 1 0 1.0000
Other drugs
 CCB 12 3 0.3787
 ACEI 11 3 0.5410
 ARB 17 5 0.3064
 CCB + ACEI 0 2 0.0989
 CCB + ARB 18 5 0.2433
 ASP 28 12 0.7605
 Statins/Brates 17 7 0.7553
HP [n, (%)] 58 (79.5) 18 (52.9) 0.005
FBG (mmol/L) 7.21 ± 3.30 7.33 ± 3.05 0.649
HbAlC (%) 7.47 ± 1.70 7.69 ± 2.16 0.456
TC (mmol/L) 4.38 ± 1.16 4.69 ± 1.05 0.375
TG (mmol/L) 1.45 ± 0.94 2.01 ± 1.07 0.012
HDL-C (mmol/L) 1.23 ± 0.28 1.21 ± 0.41 0.830
LDL-C (mmol/L) 2.53 ± 0.89 2.57 ± 0.79 0.284
UA (umol/L) 335.16 ± 99.02 321.13 ± 91.65 0.501
Cr (umol/L) 80.07 ± 17.71 74.29 ± 25.65 0.655
  1. The difference was compared using the independent sample t test or χ2 test
  2. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, TZD thiazolidinedione, CCB Calcium Channel Blocker, ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, HP hypertension, FBG fast blood glucose, HbA1C hemoglobin A1c, TC total cholesterol, TG triglyceride, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, UA uric acid, Cr Creatinine